| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |